Literature DB >> 17909290

Crystallization and preliminary X-ray characterization of arylamine N-acetyltransferase C (BanatC) from Bacillus anthracis.

Benjamin Pluvinage1, Inés Li de la Sierra-Gallay, Marta Martins, Nilusha Ragunathan, Jean-Marie Dupret, Fernando Rodrigues-Lima.   

Abstract

The arylamine N-acetyltransferase (NAT) enzymes are xenobiotic metabolizing enzymes that have been found in a large range of eukaryotes and prokaryotes. These enzymes catalyse the acetylation of arylamine drugs and/or pollutants. Recently, a Bacillus anthracis NAT isoform (BanatC) has been cloned and shown to acetylate the sulfonamide antimicrobial sulfamethoxazole (SMX). Subsequently, it was shown that BanatC contributes to the resistance of this bacterium to SMX. Here, the crystallization and the X-ray characterization of BanatC (Y38F mutant) are reported. The crystals belong to the tetragonal space group P4(1)2(1)2 or P4(3)2(1)2, with unit-cell parameters a = b = 53.70, c = 172.40 A, and diffract to 1.95 A resolution on a synchrotron source.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909290      PMCID: PMC2339728          DOI: 10.1107/S1744309107041814

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  12 in total

1.  Structure of arylamine N-acetyltransferase reveals a catalytic triad.

Authors:  J C Sinclair; J Sandy; R Delgoda; E Sim; M E Noble
Journal:  Nat Struct Biol       Date:  2000-07

2.  Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase.

Authors:  Isaac M Westwood; Simon J Holton; Fernando Rodrigues-Lima; Jean-Marie Dupret; Sanjib Bhakta; Martin E M Noble; Edith Sim
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

Review 3.  Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferases.

Authors:  Jean-Marie Dupret; Fernando Rodrigues-Lima
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

4.  Acetyl-coenzyme A: arylamine N-acetyltransferase. Role of the acetyl-enzyme intermediate and the effects of substituents on the rate.

Authors:  B Riddle; W P Jencks
Journal:  J Biol Chem       Date:  1971-05-25       Impact factor: 5.157

Review 5.  Anthrax.

Authors:  M Mock; A Fouet
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

6.  Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism.

Authors:  A M Upton; A Mushtaq; T C Victor; S L Sampson; J Sandy; D M Smith; P V van Helden; E Sim
Journal:  Mol Microbiol       Date:  2001-10       Impact factor: 3.501

7.  The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.

Authors:  James Sandy; Adeel Mushtaq; Akane Kawamura; John Sinclair; Edith Sim; Martin Noble
Journal:  J Mol Biol       Date:  2002-05-10       Impact factor: 5.469

8.  The conserved glycine/alanine residue of the active-site loop containing the putative acetylCoA-binding motif is essential for the overall structural integrity of Mesorhizobium loti arylamine N-acetyltransferase 1.

Authors:  Noureddine Atmane; Julien Dairou; Delphine Flatters; Marta Martins; Benjamin Pluvinage; Philippe Derreumaux; Jean-Marie Dupret; Fernando Rodrigues-Lima
Journal:  Biochem Biophys Res Commun       Date:  2007-07-17       Impact factor: 3.575

9.  Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance.

Authors:  Benjamin Pluvinage; Julien Dairou; Odile M Possot; Marta Martins; Agnès Fouet; Jean-Marie Dupret; Fernando Rodrigues-Lima
Journal:  Biochemistry       Date:  2007-05-19       Impact factor: 3.162

Review 10.  Arylamine N-acetyltransferases.

Authors:  Edith Sim; Isaac Westwood; Elizabeth Fullam
Journal:  Expert Opin Drug Metab Toxicol       Date:  2007-04       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.